Coya Therapeutics amends filing to name Mark Pavao to audit committee
COYA•Amended filing updates board committee assignments
Coya Therapeutics filed an amended Form 8-K to update board committee assignments disclosed in its March 29, 2026 report.
- Mark H. Pavao was appointed to the board’s Audit Committee on Aug. 6, 2026, effective immediately.
- The Audit Committee now includes Dov Goldstein as chair, Ann Lee, Dieter Weinand, and Mark H. Pavao.
